Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.77 |
| ▸ | TGM2 | P21980 | 1/20 | 0.60 |
| ▸ | IMPDH2 | P12268 | 6/20 | 0.59 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.59 |
| ▸ | KRAS | P01116 | 6/20 | 0.59 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.58 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12714661 | 0.96 | NT5E (0.84) | NT5ETGM2KRASPOLB | |
| SCHEMBL17586739 | 0.92 | NT5E (0.69) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL2315499 | 0.92 | NT5E (0.69) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL29355115 | 0.89 | TGM2 (0.65) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL12714665 | 0.89 | NT5E (0.84) | NT5ETGM2KRASTAS1R3TAS1R1 | |
| SCHEMBL22434694 | 0.89 | NT5E (0.65) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL18320601 | 0.88 | NT5E (0.72) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL10037916 | 0.88 | NT5E (0.68) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL5828417 | 0.88 | NT5E (0.68) | NT5ETGM2IMPDH2IMPDH1KRAS | |
| SCHEMBL10067882 | 0.88 | NT5E (0.68) | NT5ETGM2IMPDH2IMPDH1KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| EP-3681504-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | Icagen, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| WO-2019055754-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |